Key facts
- It has raised $9.1M; the latest was Early Stage VC ($3.8M) in Dec 2024.
- Notable investors include Backed by Dentists.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for SpinaFX
- ·The full record, as it builds
Funding rounds
No funding rounds for SpinaFX are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About SpinaFX
Operator of a medical device company intended to bring minimally invasive image-guided treatments to patients with back pain due to herniated discs. The company specializes in offering technology that provides surgeons with an early alternative to conventional surgery, using a tiny needle to inject a controlled oxygen formulation into the affected disc, safely reducing the herniation and inflammation causing pain, enabling patients to have painless treatment options for back pain.
- Sector
- Healthcare
- HQ
- Toronto, Canada
- Founded
- 2021
- Employees
- 7
- Website
- spinafx.com/
- Ownership
- Privately Held (backing)
SpinaFX doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in SpinaFX shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on SpinaFX in its N-PORT filings yet. We sweep new filings monthly.